Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merete Storgaard

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
European Journal of Neurology|February 9, 2026
Findings on Magnetic Resonance Imaging in Neuroborreliosis-A Nationwide Cohort StudyMathilde Ørbæk, Nitesh Shekhrajka, Rosa Maja Møhring Gynthersen, et al.
Journal of the Neurological Sciences|November 1, 2020
CT and MR neuroimaging findings in patients with Lyme neuroborreliosis: A national prospective cohort studyMathilde Ørbæk, Jacob Bodilsen, Rosa M Møhring Gynthersen, et al.
Journal of Neurology|May 18, 2024
Validation of a risk score to differentiate autoimmune and viral encephalitis: a Nationwide Cohort Study in DenmarkLasse Fjordside, Mette Scheller Nissen, Anna Maria Florescu, et al.
Annals of Work Exposures and Health|April 30, 2022
SARS-CoV-2 Infection Rates Following Use of Regular Compared With Defective Respirators When Caring for COVID-19 Patients: A Retrospective Follow-up StudyHenrik A Kolstad, Morten Frydenberg, Kent Jacob Nielsen, et al.
Clinical and Experimental Immunology|April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised PatientsIda M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.
British Journal of Clinical Pharmacology|December 15, 2022
Experience with sotrovimab treatment of SARS-CoV-2-infected patients in DenmarkLine Dahlerup Rasmussen, Anne-Mette Lebech, Anne Øvrehus, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2026
Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2Michelle Møhlenberg, Sofie Eg Jørgensen, Renée Marije van der Sluis, et al.
Infectious Diseases (London, England)|March 11, 2023
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasoneCæcilie Leding, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Eclinicalmedicine|April 27, 2021
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trialJesper D Gunst, Nina B Staerke, Marie H Pahus, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
European Journal of Neurology|February 9, 2026
Findings on Magnetic Resonance Imaging in Neuroborreliosis-A Nationwide Cohort StudyMathilde Ørbæk, Nitesh Shekhrajka, Rosa Maja Møhring Gynthersen, et al.
Journal of the Neurological Sciences|November 1, 2020
CT and MR neuroimaging findings in patients with Lyme neuroborreliosis: A national prospective cohort studyMathilde Ørbæk, Jacob Bodilsen, Rosa M Møhring Gynthersen, et al.
Journal of Neurology|May 18, 2024
Validation of a risk score to differentiate autoimmune and viral encephalitis: a Nationwide Cohort Study in DenmarkLasse Fjordside, Mette Scheller Nissen, Anna Maria Florescu, et al.
Annals of Work Exposures and Health|April 30, 2022
SARS-CoV-2 Infection Rates Following Use of Regular Compared With Defective Respirators When Caring for COVID-19 Patients: A Retrospective Follow-up StudyHenrik A Kolstad, Morten Frydenberg, Kent Jacob Nielsen, et al.
Clinical and Experimental Immunology|April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised PatientsIda M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.
British Journal of Clinical Pharmacology|December 15, 2022
Experience with sotrovimab treatment of SARS-CoV-2-infected patients in DenmarkLine Dahlerup Rasmussen, Anne-Mette Lebech, Anne Øvrehus, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2026
Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2Michelle Møhlenberg, Sofie Eg Jørgensen, Renée Marije van der Sluis, et al.
Infectious Diseases (London, England)|March 11, 2023
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasoneCæcilie Leding, Jacob Bodilsen, Christian Brieghel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2021
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort StudyThomas Benfield, Jacob Bodilsen, Christian Brieghel, et al.
Eclinicalmedicine|April 27, 2021
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trialJesper D Gunst, Nina B Staerke, Marie H Pahus, et al.
Pageof 11